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ttp://dx.doi.org/10.1016/j.ajpath.2013.08.015Protein phosphorylation is a dynamic post-translational modiﬁcation. Mass spectrometryebased quanti-
tation was performed to determine the phosphoproteome proﬁle of epithelial cells in response to injury,
nucleotide, or epidermal growth factor. Phosphotyrosine enrichment used immunoprecipitation and
immobilizedmetal afﬁnity chromatography. Nucleotides released after scratchwounding activate purinergic
receptors, leading to a distinct phosphorylationproﬁle on epidermal growth factor receptor (EGFR) compared
with its natural ligand. ATP induced a 2- to 15-fold phosphorylation increase over control on EGFR Y974,
Y1086, and Y1148,withminimal phosphorylation intensity on EGFRY1173 comparedwith the levelmeasured
in response to epidermal growth factor. Differential phosphorylation induced by epidermal growth factor or
ATP was site speciﬁc on Src, Shc, phospholipase Cg, protein kinase C, focal adhesion kinase, paxillin, and
mitogen-activated protein kinases 1, 12, and 13. After wounding, the P2Y2 receptor mRNA expression
increased, and after knockdown, migration and Ca2þ mobilization were impaired. To examine phosphory-
lation mediated by P2Y2, cells were cultured in media containing stable isotope-labeled amino acids, the
receptor was knocked down, and the cells were stimulated. Mass spectrometryebased comparison of the
phosphorylation proﬁles of control versus transfected cells revealed a 50-fold decrease in phosphorylation of
EGFRY974 and1086,withnodecrease in Y1173phosphorylation. A similarfolddecrease in Src Y421 andY446
and paxillin Y118 was detected, indicating the far-reaching importance of the P2Y2 receptor in mediating
migration. (Am J Pathol 2013, 183: 1841e1852; http://dx.doi.org/10.1016/j.ajpath.2013.08.015)Supported by NIH grants EY06000 and EY06000S and the New England
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Current address of A.K., Buck Institute, Novato, CA.Physical injury, mechanical stimuli, and cellular stress in-
duce the release of endogenous nucleotides to the extra-
cellular milieu.1e3 These nucleotides mediate a wide range
of signaling on activation of purinergic receptors, which
have two distinct classes: the ligand-gated P2X receptors
and the G-coupled P2Y receptors. To date, eight P2Y re-
ceptor subtypes (P2Y1, 2, 4, 6, and 11e14) have been cloned.
4,5
The receptor subtypes (P2Y1, 2, 4, 6, and 11) are expressed in
corneal epithelial cells.3 Activation of the P2Y receptors
results in the recruitment of the heterotrimeric G-proteins, and
changes in distinct signaling pathways, by either inducing
Ca2þ release from intracellular stores or directly affecting
intracellular signaling proteins, resulting in changes in cell
migration and wound repair.3,6e8
The P2Y receptor subtypes are cell-type and ligand spe-
ciﬁc, enabling them to play several regulatory roles.9 P2Y2stigative Pathology.
.and P2Y4 receptors mediate ATP-induced activation of the
protein kinase C/mitogen-activated protein kinase (MAPK)
and protein kinase C/SRC pathways in the human breast
cancer epithelial cell line MCF-7.10 The P2Y2 receptor has
been shown to mediate metalloproteinase-dependent phos-
phorylation of epidermal growth factor receptor (EGFR) in
human salivary gland cells,11 whereas the P2Y2 and P2Y6
receptors are responsible for the Ca2þ response in neuronal
and glial cells, respectively.12 In corneal epithelial cells,
Kehasse et alactivation via nucleotides or injury induces a rapid and
transient phosphorylation of extracellular signalerelated
kinase (ERK). Likewise, treatment of the wound media with
apyrase inhibits the mobilization of Ca2þ and results in
decreased p-ERK, p-EGFR, and cell migration.3,8
The EGFR facilitates rapid wound healing in corneal epi-
thelium, and studies showed that nucleotide-induced EGFR
activation is mediated, in part, by the activation of membrane-
anchored metalloproteinases, followed by ectodomain shed-
ding of HB-EGF.3,13,14 However, HB-EGF is only one of the
components of thewoundmedia.14 Furthermore, stimulation of
epithelial cells by injury or with exogenous nucleotides causes
activation of purinergic receptors, followed by transient EGFR
phosphorylation and internalization that is distinct from that
induced by EGF.14 Because EGFR phosphorylation sites serve
as docking sites for downstream signaling proteins,14e18 the
phosphorylation of EGFR tyrosine residuesmay result in either
an increase or a decrease in the phosphorylation of neighboring
residues. Although activation of the EGFR with EGF and HB-
EGF causes recruitment of Shc, growth factor receptor-bound
protein 2, and Src, activation of purinergic receptors elicits a
differential recruitment of Shc and growth factor receptor-
bound protein 2; however, there is no apparent difference in
Src.14 Cross communication between different signaling
pathways serves to integrate responses to different external
stimuli the cell receives.19e21Wehypothesize that activation of
the P2Y2 receptor results in distinct post-translational modiﬁ-
cation of the EGFR, nonereceptor-type kinases, and other
structural proteins that serve as a key link between the stimulus
and signaling pathways that lead to corneal wound repair.
The goal of the present study was to ask if differential
phosphorylation occurs in response to nucleotides or EGF,
and to distinguish the responses. Although activation of the
EGFR by its natural ligand yielded prototypical phosphor-
ylation of tyrosine residues, ATP stimulation caused a 2- to
15-fold increase over control in EGFR Y974, Y1086, and
Y1148 residues and a distinct difference in phosphoryla-
tion pattern of downstream signaling proteins, with ATP
inducing a greaterfold increase in phosphorylation than EGF
on Src Y421 but less at other sites on Src and phospholipase
C (PLC)-g. In addition, ATP induced a greaterfold increase
in phosphorylation than EGF on speciﬁc residues of the
kinases common to the P2YR and EGFR signaling networks
[protein kinase C (PKC), focal adhesion kinase (FAK), and
MAPKs 1, 12, and 13]. Additional post-translational
modiﬁcation changes were detected in paxillin, in which
four residues showed a higher phosphorylation. Analysis
of cell migration after a scratch wound revealed an up-
regulation in P2Y2 receptor mRNA. Stimulation with UTP
(agonist for P2Y2) after siRNA knockdown resulted in a
decrease in phosphorylation of major downstream signaling
proteins, including Y1086 and Y974 residues of EGFR, Src,
and paxillin. Our results indicate that the initial activation of
receptors plays a major role in the differential phosphory-
lation of signaling molecules, permitting cells to mediate
downstream events.1842Materials and Methods
Materials
Keratinocyte serum-free medium (K-SFM), bovine pituitary
extract, fetal bovine serum, and penicillin/streptomycin
were purchased fromMediatech (Manassas, VA). Fungizone,
Lipofectamine, antibodies directed against site-speciﬁc
phosphotyrosine residues of EGFR (pY845, pY1068,
pY1086, and pY1173), Dynabeads protein G, and PCR kits
(oligo-dT primers, 10 reaction buffer, MgCl2, dNTPs,
MoloneyMurine Leukemia Virus Reverse Transcriptase, and
random primers) were purchased from Invitrogen (Carlsbad,
CA). Acetoxymethyl (AM) ester derivatives of ﬂuorescent
indicators (Fluo-3 AM) were purchased from Invitrogen. C-
18-Stage tips and CaCl2 were from Thermo Fisher Scientiﬁc
(Cambridge, MA). Phosphotyrosine antibody T66, ATP,
ADP, UTP, dithiothreitol, ammonium acetate, triﬂuoroacetic
acid, acetic acid, Nonidet P-40 (NP-40), glycine, 2-amino-2-
hydroxymethyl-propane-1,3-diol,HCl (Tris-HCl), sodium
chloride (NaCl), sodium deoxycholate, EDTA, bicinchoninic
acid (BCA), and ureawere purchased fromSigmaAldrich (St.
Louis, MO). siRNA sequences targeted against P2YR2,
P2YR4, or a scrambled sequence [nontargeting (NT)] were
from Dharmacon (Lafayette, CO). DNase I was from New
England Biolabs (Ipswich, MA). RNase inhibitor, complete
protease inhibitor cocktail, and PhosSTOP Phosphatase In-
hibitor Cocktail were purchased from Roche Applied Science
(Indianapolis, IN). Polyvinylidene diﬂuoride membrane was
from Pierce (Rockford, IL). Anti-phosphotyrosine antibody
4G10 was purchased from Millipore (Billerica, MA). Anti-
EGFR antibody and horseradish peroxidaseeconjugated
secondary antibody were purchased from Santa Cruz Bio-
technologies (Santa Cruz, CA). Western Lightning was pur-
chased from GE Healthcare Bio-Sciences Corp (Piscataway,
NJ). Phosphotyrosine antibody (PY100) was from Cell
Signaling Technology (Danvers, MA). Stable isotope-labeled
lysine and arginine containing 13C and/or 15N were pur-
chased from Cambridge Isotope Laboratories (Andover, MA).
C-18 reversed-phase material (MagicC18AQ) of 3- and 5-mm
particle size and 200-Å pore sizewas purchased fromMichrom
Biosciences (Auburn, CA). Microcapillary columns of 75/100
mm inner diameter and 360 mm outer diameter were obtained
from Polymicro Technologies (Phoenix, AZ). Trypsin was
purchased from Worthington (Lakewood, NJ). The RNA
extraction kit was purchased from Qiagen (Valencia, CA).
TaqMan probes were purchased from Applied Biosystems
(Foster City, CA). Iodoacetamide and sample buffer were
purchased from Bio-Rad Laboratories (Irvine, CA).Cell Culture
Human corneal limbal epithelial cells (HCLEs) were cultured
in K-SFM supplemented with 30 mg/mL bovine pituitary
extract, 0.032 nmol/L EGF (Invitrogen), 100 U/mL penicillin,
and 100 mg/mL streptomycin (Mediatech).14 Twenty-fourajp.amjpathol.org - The American Journal of Pathology
Phosphorylation of Signaling Proteinshours before experimentation, EGF and bovine pituitary
extract were removed.
siRNA Transfection
Cells were cultured until 50% to 60% conﬂuency and
transfected as described.7 Optimization experiments with
multiple siRNA sequences were used individually or as part
of a four-sequence pool, and the sequences resulting in the
largest down-regulation of transcripts, as assayed by real-
time PCR, were used for further experimentation. Experi-
ments were performed using the same four-sequence pool or
the two individual sequences (D-003688-01 or D-003688-
09 and D-005693-05 or D-005693-03), which showed re-
sponses equivalent to the pool described.7 Sequences used
for P2Y2 include the following: (01) 50-CAACAUGGCC-
UACAAGGUUUU-30 (sense) and 50-AACCUUGUAGG-
CCAUGUUGUU-30 (antisense); (09)50-GAACUGACA-
UGCAGAGGAUUU-30 (sense) and 50-AUCCUCUGCAU-
GUCAGUUCUU-30 (antisense); (04) 50-GCAGAGGCUC-
GUACGCUUUUU-30 (sense) and 50-AAAGCGUACGA-
GCCUCUGCUU-30 (antisense); and (902) 50-GGAAUGC-
GUCCACCACAUAUU-30 (sense) and 50-UAUGUGGUG-
GACGCACAUAUU-30 (antisense). Control nontargeting
sequences were transfected as control. Lipofectamine and
siRNA sequences were incubated separately in K-SFM
supplemented with 30 mg/mL bovine pituitary extract and
0.032 nmol/L EGF without antibiotics, at room temperature.
Mixtures were combined, incubated, and added to cells at a
ﬁnal concentration of 2 mL/mL Lipofectamine and 20 nmol/L
siRNA. After 6 hours, the transfection medium was replaced
with growth medium.
Real-Time Quantitative PCR
Total RNA was extracted using a Qiagen RNeasy kit, ac-
cording to the manufacturer’s protocol. Genomic DNA was
removed by incubation with DNase I in the presence of 1 U/
mL RNase inhibitor. First-strand cDNA was enzymatically
synthesized from the DNase-treated RNA templates using
the Moloney murine leukemia virusereverse transcriptase,
and the control RT reaction lacked the reverse transcriptase.
The TaqMan Gene Expression Master Mix (Applied Bio-
systems, Grand Island, NY) was used, and real-time PCR
was performed using an ABI 7300 (Applied Biosystems,
Foster City, CA). The following TaqMan probes were used:
Hs00704965_s1 for P2Y1, Hs00602525_m1 for P2Y2,
Hs00267404_s1 for P2Y4, and the eukaryotic 18S ribosomal
RNA endogenous control for the 18S ribosomal subunit
(VIC/MGB Probe, Primer Limited; Applied Biosystems,
Grand Island, NY). cDNA templates were incubated at 50C
for 2 minutes and 95C for 10 minutes, and that was followed
by 40 to 50 ampliﬁcation cycles of 95C for 15 seconds and
60C for 1 minute. Results were presented as relative ex-
pression normalized to 18S ribosomal RNA and calculated
using the DDCT method.
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Cells were washed with cold PBS and lysed in radioim-
munoprecipitation assay buffer (150 mmol/L NaCl, 50
mmol/L Tris-HCl, pH 7.4, 1% NP-40, 1% deoxycholate, and
5 mmol/L EDTA) supplemented with complete protease in-
hibitor cocktail and PhosSTOP Phosphatase Inhibitor Cock-
tail (Roche Applied Science). Lysates were incubated at
80C for 20 minutes and centrifuged at 4C at 13,500  g
for 20 minutes, and supernatants were transferred to a new
tube. Total protein concentration was determined using a
BCA-based method, samples were subjected to SDS-PAGE,
and proteins were transferred to a polyvinylidene diﬂuoride
membrane. Immunoblots were blocked using 5% bovine
serum albumin in Tris-buffered saline andTween-20 (TBS-T)
for 2 hours at room temperature or overnight at 4C, as
appropriate. Membranes were probed with primary anti-
bodies (1:1000) directed to phosphotyrosine or site-speciﬁc
phosphotyrosine residues of EGFR (pY845, pY1068,
pY1086, and pY1173) overnight at 4C, washed with TBS-T,
and incubated with horseradish peroxidaseeconjugated sec-
ondary antibody (1:2000) for 1 hour at room temperature.
Membranes were washed with TBS-T and exposed using
Western Lightning (Perkin Elmer, Waltham, MA), and sig-
nals were quantiﬁed using ImageJ software version 1.48
(NIH, Bethesda, MD).
Scratch Wound Assay
The scratch wound assay and imaging analysis have been
described.14 Scratch wounds were made using a gel loader
tip, and the medium was removed and replaced with un-
supplemented medium (control) or supplemented medium
containing one of the following ligands (ADP, ATP, UDP,
UTP, or EGF). In additional experiments performed to
determine the response to UTP, cells were lysed at time
points to determine the expression of P2Y receptors. Cul-
tures were transfected with NT or siRNA to P2Y2 receptor
following the protocol previously described and then
wounded and cultured in media in the presence or absence
of UTP. Slides were placed on the stage of a laser-scanning
confocal microscope (Zeiss Axiovert 200M LSM 510;
Zeiss, Thornwood, NY), and wound locations were marked.
Slides were placed in an environmental chamber, and cells
were incubated at 37C and 5% CO2. Cell migration was
monitored using the multitime module of the LSM software
version 4.0 (Zeiss). Images were taken at each location
every 20 minutes for 16 hours, as described.14 Wound areas
at various time points were measured using the proprietary
LSM software version 4.0, and percentage wound closure
was calculated.
Ca2þ Mobilization
Brieﬂy, cells were transferred into HEPES-buffered saline
solution and loaded with 5 mmol/L Ca2þ indicator dye ﬂuo 3-1843
Kehasse et alAM solution containing 0.02% pluronic acid/dimethyl sulf-
oxide.3,6,7 Cells were washed to remove excess dye and
imaged using a Zeiss Axiovert 100M LSM 510 confocal mi-
croscope equipped with argon and two HeNe lasers (Zeiss).
Cells were perfused with HEPES before injury with a micro-
manipulator to establish a baseline ﬂuorescence reading. All
perturbations were conducted while cells were continuously
scanned using a Harvard apparatus perfusion chamber.
Preparation of Cell Lysates for Mass Spectrometry
HCLEs were stimulated with ATP, EGF, or media change
(control) for 5 minutes and lysed with 8 mol/L urea in 50
mmol/L Tris-HCl and 75 mmol/L NaCl, pH 8.2, supple-
mented with a complete protease inhibitor cocktail and
PhosSTOP Phosphatase Inhibitor Cocktail. For absolute
quantitative phosphorylation analysis, cells were cultured in
the presence of stable isotope-labeled amino acids in cell
culture (SILAC), using a custom-madeK-SFM supplemented
with isotope-labeled lysine (12C6,
14N2 Z light and
13C6,
15N2 Z heavy) and arginine (
12C6,
14N4 Z light and
13C6,
15N4 Z heavy). Protein concentration was determined by
BCA. An average of 10 mg total protein was reduced, with a
ﬁnal concentration of 10mmol/L dithiothreitol in 100mmol/L
ammonium acetate, pH 8.9, for 1 hour at 56C, and free cys-
teines were alkylated, with a ﬁnal concentration of 55 mmol/L
iodoacetamide in 100 mmol/L ammonium acetate, pH 8.9,
for 1 hour in the dark. After the concentration of urea was
reduced to 1.5mol/Lwith 100mmol/L ammonium acetate, pH
8.9, proteins were digested with trypsin at a 1:50 trypsin/
protein ratio for 16 hours at room temperature. Digested ly-
sates were acidiﬁed to pH <3 with triﬂuoroacetic acid,
desalted with a C18 Sep-Pak Plus cartridge (Waters Corp,
Milford, MA), eluted with 25% acetonitrile/0.1% acetic acid,
and lyophilized to dryness.
Phosphopeptide Immunoprecipitation
Phosphopeptide immunoprecipitation was performed, as
described, with the followingmodiﬁcation.22 Brieﬂy, a 60-mL
volume of Dynabeads protein G (Life Technologies, Grand
Island, NY) was washed with immunoprecipitation buffer
(100mmol/L Tris, 100mmol/LNaCl, and 1%NP-40, pH 7.4)
and incubated with a combination of three anti-
phosphotyrosine antibodies (PY100, T66, and 4G10) at 4C
for 8 hours on a rotator. The antibody-bead conjugates were
centrifuged, and the beadswere removed using amagnetic bar
and washed with immunoprecipitation buffer. Lyophilized
peptides were resuspended and incubated with the antibody-
conjugated beads at 4C in a rotator overnight, and the
bead-antibody-peptide complex was separated using a mag-
netic bar. Beads were washed with 100 mmol/L Tris-HCl, pH
7.4. Phosphopeptides were eluted twice with 100 mmol/L
glycine, pH 2.5, for 30 minutes at room temperature, com-
bined, and vacuum dried in a SpeedVac (ThermoScientiﬁc,
Waltham, MA).1844Phosphopeptide Enrichment and Liquid
ChromatographyeTandem Mass Spectrometry
Dried peptides were phosphoenriched using immobilized
metal afﬁnity chromatography (IMAC) and desalted using a
stage tip (C-18), as described.23 Phosphoenriched peptides
were redissolved in 99% water, 1% CH3CN, and 0.1%
formic acid and injected into a nanoAcuity Ultra Perfor-
mance Liquid Chromatography (Waters Corp) coupled
through a TriVersa NanoMate robot (Advion, Ithaca, NY) to
an Linear Ion Trap-Orbitrap Discovery Electron Transfer
Dissociation (Thermo Fisher Scientiﬁc, San Jose, CA) mass
spectrometer. The metal components of the sample intro-
duction pathway had been replaced with inert materials.
Trapping was performed using a self-packed C-18 reversed-
phase microcapillary column (MagicC18AQ; 5-mm particle
size and 200-Å pore size; 10-cm bed length; 360-mm OD 
100-mm ID). A 10-cm microcapillary analytical column
(360-mm OD  75-mm ID; 10-cm bed length) was packed
with C-18 reversed-phase material (MagicC18AQ) of 3-mm
particle size and 100-Å pore size. The mobile buffer A,
consisting of 99% H2O, 1% CH3CN, and 0.1% PBS, was
run with the elution buffer B, of 99% CH3CN, 1% H2O, and
0.1% PBS over a 90-minute gradient with a ﬂow rate of 0.5
mL/minute. The LTQ-Orbitrap was operated in a data-
dependent mode in which each full MS scan (m/z 300 to
2000 with 60,000 resolution at m/z 400) was followed by
ion-trap MS/MS scans of the ﬁve most abundant ions.
Mass Spectrometry Data Analysis
The data from triplicate runs for each sample were used for
label-free quantitative phosphopeptide analysis using Pro-
genesis liquid chromatographyemass spectrometry (LC-
MS; Nonlinear Dynamics, Durham, NC). Modiﬁed peptides
with identiﬁcation power of 0.8 and P  0.05 were ﬁltered
and exported for a database search. The database search was
performed against the SwissProt human database using the
Mascot search engine, version 2.3.02 (Matrix Science,
Boston, MA). Carbamidomethylation of cysteine was set as
a ﬁxed modiﬁcation. Oxidation of methionine and phos-
phorylation of tyrosine, serine, and threonine were set as
variable modiﬁcations. A maximum of two missed cleav-
ages was set, with trypsin as the protease. Mascot results
were ﬁltered with 10-ppm precursor ion mass tolerance and
MS/MS tolerance of 0.8 Da for peptide fragment ions. Data
from SILAC-labeled samples were analyzed using Proteome
Discoverer version 1.2 (Thermo Fisher Scientiﬁc, San Jose)
using similar search parameters as previously described. For
quantitative analysis, the ratio (heavy/light) of phosphosite
occupancy was calculated.
Statistical Analysis
For each identiﬁed phosphorylation site, fold increase over
control was calculated from the normalized average relativeajp.amjpathol.org - The American Journal of Pathology
Table 1 Label-Free Quantitative Tyrosine Phosphorylation Proﬁle of a Subset of Average Normalized Abundances in the Tyrosine Phos-
phorylation Proﬁle Determined from HCLEs Treated with Control (Media Change), ATP, or EGF
Protein Modiﬁcations m/z
Running time
(minutes) Charge
ANOVA
(P) (10-2) Fold
Average normalized abundances
(103)
Control ATP EGF
EGFR p-Tyr-974 548.9004 30.4 3 0.0000104 46.7 13.8 69.5 325
p-Tyr-1086 827.0708 24.7 3 0.000147 39.7 6.96 51.9 312
p-Tyr-1148 772.6703 33.9 3 0.000435 142.2 13.1 266 1870
p-Tyr-1173 759.0297 27.4 3 0.0000255 351.7 4.53 2.43 856
KPCD p-Tyr-313 940.9012 29.7 2 0.00000962 13.67 6.65 91.2 23.3
p-Ser-304 706.2921 29.2 3 0.000751 12.4 2.85 35.3 21.3
MAPK-13 p-Tyr-182 765.3261 24.3 2 2 9.7 5.29 51.7 11.2
p-Tyr-258 574.5929 25.7 3 0.0172 53.1 0.565 0.132 7.02
MAPK-12 p-Tyr-185 816.8103 27.6 2 0.1 29.8 2.59 10.4 0.348
MAPK-1 p-Tyr-187 741.9948 29.7 3 1.7 23.7 130 1730 731
p-Thr-190 1112.489 29.7 2 0.000184 88.7 8.74 70 0.789
p-Thr-185 768.6503 30.9 3 1 9.1 39.4 359 143
PLCG1 p-Tyr-771 846.3689 29.1 2 0.000818 15.3 7.7 73.2 118
p-Tyr-227 896.3942 36.5 2 1 8 1.66 3.65 13.3
RIN1 p-Tyr-36 948.1138 27.9 3 0.2 11.9 26 310 133
CDK2 p-Tyr-15 541.2668 26.6 3 0.00000816 192.2 1.46 0.369 71
CDC42-K p-Tyr-827 739.3634 27.5 2 0.0676 29.1 1.6 11.3 0.389
p-Tyr-859 605.3012 30.4 4 0.00207 49.5 2.3 14.6 114
p-Tyr-860 806.7332 30.5 3 0.0251 10.4 3.01 3.43 31.3
SHC1 p-Tyr-427 1102.007 34.3 2 0.00303 196.7 2.45 1.62 319
p-Tyr-315 457.5704 21.2 3 0.000967 401.5 0.546 0.122 48.8
SHB p-Tyr-246 818.8424 25.7 2 0.000301 34.4 4.07 38.9 1.33
p-Tyr-268 641.9358 24.1 3 0.7 8.2 4.38 3.27 26.8
p-Tyr-98 817.3299 28.5 2 0.0306 9.1 5.89 31.4 53.8
GAB1 p-Tyr-659 636.7968 24.1 2 0.000000287 29.3 1.11 30.8 1.05
p-Tyr-259 828.8849 31.5 2 0.01 14.8 4.86 72.2 19
p-Tyr-626 787.8527 33.8 2 0.00433 16.2 4.99 80.9 6.06
SRC8 p-Tyr-446 750.98 27.9 3 0.008 11.5 1.84 20 21.1
p-Tyr-421 530.9075 31.2 3 0.0411 27.3 8.55 23 6.36
PAXI p-Tyr-88 676.6452 22.3 3 3.7 7.9 47.4 374 99
p-Tyr-118 538.8987 24.8 3 4.5 12 357 4280 375
FAK p-Tyr 576/577 783.3149 21.9 2 0.0575 64.6 1.75 0.193 12.5
p-Tyr-861 880.432 28.2 4 0.000252 23.1 7.08 163 7.27
TYK2 p-Tyr-259 627.8057 25.1 4 0.00481 35.8 8.11 79.3 290
p-Tyr-292 800.3649 28.5 2 3.6 7.3 46.2 225 30.9
P85B p-Tyr-464 794.8136 29.5 2 0.5 4.4 11.2 49.6 40.6
p-Tyr-467 794.8136 29.5 2 0.5 4.4 11.2 49.6 40.6
FAK2 p-Tyr-579/580 956.3759 24.4 2 0.00625 37.6 6.65 31.7 69.3
PTK6 p-Tyr-447 663.2683 29 2 0.2 30.8 18.9 147 583
PTN11 p-Tyr-62 908.3773 29.3 2 0.3 42.8 25.3 114 2.67
p-Tyr-63 908.3773 29.3 2 0.3 42.8 25.3 114 2.67
PRP4B p-Tyr-849 1259.0596 34.1 2 1.3 6.1 15.6 95.4 28
p-Tyr-849 839.7086 34.2 3 1.4 10.3 105 1080 443
STAT3 p-Tyr-705 646.2804 24.9 4 0.00455 15.4 15.3 122 18.7
ITB4 Y-1207 714.299 29 3 2.6 3.5 8.89 25.5 31.4
CBL p-Tyr-674 787.4292 33.3 3 0.0231 56 5.43 38.4 304
Statistical signiﬁcance is calculated within the triplicate runs for each condition. Data were ﬁltered based on P values (P < 0.05). Fold change signiﬁcance
was calculated using ANOVA.
ANOVA, analysis of variance.
Phosphorylation of Signaling Proteinsintensity of the phosphorylation proﬁle generated using the
mean peak area of the total ion chromatogram. The results
obtained for a subset of the phosphorylated proteins and
modiﬁcations are given in Table 1, and the signiﬁcantThe American Journal of Pathology - ajp.amjpathol.orgdifferences in phosphorylation between treatments are calcu-
lated. The data were ﬁltered based onP values (P< 0.05), and
fold change signiﬁcance was calculated using analysis of
variance.1845
Figure 1 Role of individual nucleotides on cell migration. HCLEs grown
to conﬂuence on 8-well glass-bottom chambers were serum starved for 16
hours. Scratch wounds were made using a gel loader tip, and medium was
immediately aspirated and replaced with medium alone (Neg. Cont) or
medium containing one of the following ligands (100 mmol/L ADP, 100
mmol/L ATP, 100 mmol/L UDP, 100 mmol/L UTP, or 0.5 nmol/L EGF). Pos-
itive controls were cultures that were wounded and in which the wound
media were retained for the duration of the time course [wound media
(WM)]. Live cell migration was monitored using a laser-scanning confocal
microscope equipped with an environmental chamber that maintained the
cell environment at 37C and 5% CO2. Images were taken at each location
every 20 minutes for 16 hours. Wound closure was determined using the
region of interest function of the LSM software version 4.0, and percentage
wound closure was calculated. Wound closure is indicated by the average
closure at each time point  SEM. Data are representative of three inde-
pendent experiments.
Figure 2 Quantitative ligand-speciﬁc phosphotyrosine proﬁle analysis.
HCLEs were stimulated with a media change (control), ATP, or EGF. Cells
were lysed and enzymatically digested, and phosphotyrosine peptides were
immunoprecipitated using three anti-tyrosine antibodies in a 1:1 solution
(PY-100, 4G10, and T66). A: The number of proteins and the corresponding
peptides and modiﬁcations are presented. B: Percentage distribution of the
phosphorylation sites (p-Tyr, p-Ser, and p-Thr). Data are representative of
two experiments, each including triplicate UPLC-MS analysis.
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Dynamic protein phosphorylation is critical for the regula-
tion of many cellular signaling mechanisms. Because there
are multiple signaling pathways induced by injury that
involve the activation of EGFR, knowledge of the speciﬁc
changes will enhance our understanding in regulation of cell
migration and wound repair.
Role of Nucleotides on Cell Migration
Previous studies have shown that nucleotides and growth
factors enhance cell migration in Boyden chamber assays.3 In
addition, we have shown that EGFR is necessary for
nucleotide-induced cell migration by either using tyrosine ki-
nase inhibitors or mutating speciﬁc residues in scratch wound
assays.14 To determine the response to individual nucleotides,
scratch wounds were made and migration was monitored
every 20 minutes for 16 hours. At the ﬁnal time point, the gap
generated by the scratch wound had decreased by >60% in
response to all agonists, except for ADP (Figure 1). The pos-
itive control, in which wounded cultures contained the wound
media, demonstrated an 80% gap closure (Figure 1).
MS-Based Quantitative Analysis of Phosphorylation
Proﬁle
In global MS-based phosphoproteome studies,24e26 detec-
ted levels of phosphotyrosine modiﬁcation in peptides were
lower than the levels of phosphoserine and phospho-
threonine modiﬁcations after treatment of cells with agonist1846for 5 minutes. Therefore, we used phosphotyrosine peptide
immunoprecipitation using three anti-phosphotyrosine anti-
bodies to enrich the detection level of phosphotyrosine
residues in the samples subjected to LC-MS analysis. Initial
analysis using database searches on each data set with
Proteome Discoverer generated a total of 20, 141, and 168
phosphorylation modiﬁcation sites in the control, ATP, and
EGF treatment groups, respectively (Figure 2A). ATP was
used to stimulate cells because it activates most purinergic
receptors and, thus, gave a global response. The phospho-
tyrosine contribution observed under all treatment condi-
tions was approximately 50% of the total phosphopeptides
identiﬁed (Figure 2B). The immunoprecipitates were dried
and further phosphoenriched using IMAC, yielding a per-
centage distribution of phosphotyrosine containing peptides
>30% of the phosphopeptides identiﬁed by MS. Label-free
quantitative analysis using Progenesis LC-MS (Nonlinear
Dynamics) generated a list of >300 phosphorylation sites
on 139 proteins. A total of 130 phosphopeptides and pro-
teins and average normalized abundances are given
(Supplemental Table S1). The analysis is described in
Materials and Methods.
Phosphorylation of EGFR and Downstream Signaling
Proteins
Previously, we showed that EGFR was phosphorylated
indirectly by activation of purinergic receptors in a dose-ajp.amjpathol.org - The American Journal of Pathology
Figure 3 Label-free quantitative analysis of signaling proteins using Progenesis LC-MS. Normalized average relative abundances of the phosphorylation
proﬁle generated by calculating the mean peak area of the total ion chromatogram of each peptide are shown. Fold change over control of the following
phosphotyrosine and serine residues: EGFR (A), PKCD (B), PLC-g1 (C), Shc and Src (D), and FAK and paxillin (E). Phosphopeptide abundances are calculated
from the normalized average relative abundances for each phosphopeptide. Data are representative of two experiments, each including triplicate UPLC-MS
analysis (see Table 1).
Phosphorylation of Signaling Proteinsdependent manner.14,19 Five minutes after stimulation, the
data from internalization studies of the EGFR were similar
in response to EGF, nucleotides, or a scratch wound. In
addition, when cells were immunoprecipitated with EGFR
and probed for p-EGFR in response to EGF or nucleotide,
there was a signiﬁcant change in p-EGFR over untreated.14
In the current experiments, there was a differential phos-
phorylation at 5 minutes in response to ATP or EGF
(Table 1). EGF caused a 10- to 100-fold increase in phos-
phorylation over control on residues EGFR Y974, Y1086,
Y1148, and Y1173, whereas ATP caused a 2- to 15-fold
increase over control on EGFR Y974, Y1086, and Y1148
residues (Figure 3A). In contrast, ATP induced less phos-
phorylation compared with media control on Y1173
(Figure 3A). Other residues may be phosphorylated, but the
fold change over control did not ﬁt the stringency require-
ment of the analysis of variance because the data were
ﬁltered based on P < 0.05.
Kinases common to purinergic and EGFR signaling net-
works showed site-speciﬁc distinct phosphorylation patterns
in response to activation. We speculated that PKC plays a
role in the phosphorylation of EGFR via changes in mobili-
zation of Ca2þ after activation of purinergic receptors orThe American Journal of Pathology - ajp.amjpathol.orgafter cleavage of phosphatidylinositol 4,5-bisphosphate 2 to
diacylglycerol and inositol triphosphate. For PKCD, both sites
showed higher fold increases in phosphorylation in response
to ATP compared with EGF. For example, ATP caused
phosphorylation at pY313 and pS304, with 14- and 12-fold
increases in phosphorylation over control and 3- and 1.5-
fold increases over EGF stimulation, respectively (Figure 3B).
Previously, we demonstrated that the phosphorylation of
PLC-g in response to EGF decreased in the presence of
ATP.7,14 When we evaluated its phosphorylation proﬁle in
response to ATP or EGF (as positive control), there was a
differential response on two residues. Y227 showed an
eightfold increase over control in response to EGF and a
twofold increase over control in response to ATP. Likewise,
Tyr-771 showed a 14-fold increase over control, and a nine-
fold change over control in response to ATP (Figure 3C). In
addition, with ATP, we detected changes in the extent of
oxidation of methionine.
When downstream signaling proteins shown to display a
differential recruitment with Western blot analyses were
examined, we detected a differential phosphorylation in Shc
and Src. Previously, we had detected little or no change in
association of Src14 with EGFR. At a higher resolution in1847
Figure 4 Label-free quantitative analysis of MAPK using Progenesis LC-MS. Normalized average relative abundances of the phosphorylation proﬁle are
generated by calculating the mean peak area of the total ion chromatogram of each peptide are shown. Fold changes over control of MAPK phosphopeptide
abundances are calculated from the normalized average relative abundances of each phosphopeptide. Data are representative of two experiments, each
including triplicate UPLC-MS analysis (see Table 1).
Kehasse et althese studies, we found a signiﬁcant fold increase in phos-
phorylation of Y421 in response to ATP, whereas the
response to EGF was less than control. For Y446, ATP and
EGF stimulation resulted in almost equivalent, 11-fold in-
creases over control. Previously, we had shown that there was
a recruitment difference among the three Shc isoforms.14
Herein, we detected differences in phosphorylation intensity
at Y315 and Y427 (Figure 3D). Tyr-315 showed a negligible
increase in phosphorylation in response toATP andwas lower
than control. In contrast, there was an 89-fold increase in
phosphorylation over control in response to EGF. Tyr-427
showed a similar proﬁle, with no increase in phosphoryla-
tion over control in response to ATP, in contrast to a 130-fold
increase in phosphorylation over control after EGF stimula-
tion. These results indicate that association with EGFR does
not correlate with fold changes in phosphorylation.
The changes in the phosphorylation proﬁle of signaling
proteins, such as PLC-g and Src, were speculated to inﬂu-
ence the proﬁle of FAK and paxillin, adaptor adhesion ki-
nases that mediate cytoskeletal changes and cell migration.
For FAK Y576/577, there was greater than ﬁvefold increase
in response to EGF but a smaller change than control in
response to ATP. In contrast, Y861 showed a 20-fold in-
crease in response to ATP and a minimal response to EGF.
Y397 showed a negligible response to ATP (data not
shown). Downstream of FAK, paxillin showed a greater
fold response to ATP than EGF on Y88, S85/90, S9, and
Y118, with a 10-fold greater response to EGF than ATP on
S119 (Figure 3E).
Previously, we demonstrated that nucleotides induced a
rapid transient phosphorylation (2 to 10 minutes) of ERK in
response to injury that contrasted with the long-lasting
phosphorylation in response to EGF.8 Herein, we detected
ligand-speciﬁc differences in nine phosphorylation sites in
three isoforms of the MAPK family: MAPK-1, MAPK-12,
and MAPK-13. Seven of the mapped residues (T185, Y187,1848and T190 of MAPK-1, Y185 and T183 of MAPK-12, and
T180 and Y182 of MAPK-13) showed a minimum of a
fourfold increase in phosphorylation in response to ATP
over control and a twofold increase over EGF stimulation,
whereas Y258 and S261 of MAPK-12 were highly phos-
phorylated only in response to EGF (Figure 4).
Together, these data indicate that stimulation directly and
through cross activation causes a distinct response, and
when it occurs through the secondary route, recruitment of
signaling molecules and activation are modiﬁed.
P2Y Receptor Expression Changes during Wound Repair
P2Y receptor mRNA expression levels were evaluated at 0,
2, 4, 8, 12, 16, and 20 hours after injury (Figure 5A). We
found an increase in P2Y2 receptor mRNA expression 4
hours after injury and little change in P2Y1, P2Y4, and P2Y6
receptor mRNA expression over the time course of 20 hours
(Figure 5A). Because the expression of P2Y2 receptor
increased, we performed knockdown experiments to un-
derstand the role of P2Y2 on epithelial function after injury.
Veriﬁcation of transfection with siRNA to P2Y2 receptor
was compared with nontargeting sequence (Figure 5B) and
had been shown previously by our laboratory.7,14 To
examine the role of the receptor on migration, cells were
transfected with siRNA to P2Y2 or a nontargeting sequence,
and wounded and cultured in the presence of UTP, which
was used because it has the greatest potency for the P2Y2
receptor.6 Cells were imaged over 20 hours using live cell
microscopy under environmental conditions, and percentage
closure was determined at 4 and 8 hours, time points near
maximal expression and during active cell migration. Cul-
tures transfected with an NT sequence and stimulated with
UTP showed a 1.8-fold change in closure of the gap over
non-stimulated at 4 hours (Figure 5C). When cells were
transfected with the siRNA to the P2Y2 receptor, closure ofajp.amjpathol.org - The American Journal of Pathology
Phosphorylation of Signaling Proteinsthe gap was minimal at either time point. We did detect an
increase in closure in response to UTP under transfected
conditions, and we attribute this to activation of P2Y4.
Studies were performed to determine Ca2þ mobilization of
injured transfected cultures. Cultures transfected with siRNA
directed to the P2Y2 receptor exhibited minimal Ca
2þ
mobilization after scratch wound compared with cultures
transfected with siRNA to an NT sequence (Figure 5D).
We then evaluated the role of the P2Y2 receptor on
phosphorylation of EGFR tyrosine residues using Western
blot analysis. Cells transfected with siRNA to the P2Y2
receptor or NT were immunoblotted using site-speciﬁc an-
tibodies directed against EGFR tyrosine residues evaluated
previously (Y845, Y1068, Y1086, and Y1173).14 When
cells were transfected with the NT sequence, there was an
increase in the phosphorylation of Y845, Y1068, Y1086,
and Y1173 after stimulation with UTP or EGF. When cells
were transfected with siRNA to the P2Y2 receptor, there
was a detectable increase in phosphorylation in response toThe American Journal of Pathology - ajp.amjpathol.orgEGF; however, there was minimal or no increase in the
phosphorylation in response to nucleotides (Figure 5E).
These data implicated the P2Y2 receptor as a major player in
epithelial cell migration and EGFR cross activation. In
addition, they demonstrated that the phosphorylation is
complex and these results led to stable-isotope labeling of
epithelial cells to further delineate the role of the receptor.
Role of P2Y2 Receptor on EGFR Phosphorylation
SILAC is an accurate and sensitive method for quantifying
peptide and protein modiﬁcations.27,28 To test the role of the
P2Y2 receptor in regulating the nucleotide-induced phos-
phorylation proﬁle, cells were SILAC labeled with isotopi-
cally labeled lysine (K) and arginine (R) and the groups
were designated as light [12C6,
14N2(K),
12C6,
14N4(R)] or
heavy [13C6,
15N2(K),
13C6,
15N4(R)]. Cells were transfected
with siRNA directed against P2Y2, or an NT siRNA
sequence, stimulated with 100 mmol/L UTP and lysed.Figure 5 Purinergic receptor activationmediates
cell function. A: Expression of purinergic receptors
(P2Y1, P2Y2, P2Y4, and P2Y6) after scratch wound.
HCLE cultures were subjected to scratch wounds, and
at 0, 2, 4, 8, 12, 16, and 20 hours, RNA was isolated.
Real-time PCR was conducted to determine relative
expression levels of the P2Y1, P2Y2, P2Y4, and P2Y6
receptor mRNA transcripts. Data are representative of
three independent runs from three independent ex-
periments. Values are given as the means  SEM. B:
Relative expression of cells transfected with siRNA to
P2Y2 or a scrambled siRNA sequence (NT) using real-
time PCR (t-test, *P < 0.05). C: Role of P2Y2 recep-
tor on cell migration. HCLEs were transfected with
siRNA to P2Y2 receptor or NT, and scratch wounds
were made and stimulated with UTP. Cells were
monitored and images were taken at 4 and 8 hours,
wound areas were measured using the region of in-
terest of the LSM software version 4.0, and percent-
age wound closure was calculated. Data are
representative of three independent experiments. D:
P2Y2 receptor knockdown attenuates Ca
2þ mobiliza-
tion after injury. HCLEs transfectedwith siRNA to P2Y2
receptor or NT were incubated in 5 mmol/L ﬂuo 3-AM
and imaged in a ﬂow-through apparatus on a Zeiss
LSM 510 confocal microscope. Cells were perfused
with HEPES to establish baseline ﬂuorescence. Data
are representative of three independent runs, and a
representative run is graphed as percentage change in
average ﬂuorescence over time. E: Role of P2Y2 re-
ceptor activation on EGFR phosphorylation. HCLEs
were cultured, transfected with siRNA to P2Y2 or NT,
and stimulated with medium alone, UTP, ATP, or EGF.
Proteins were resolved by SDS-PAGE, and immunoblot
analysis was performed using primary antibodies
directed to site-speciﬁc phosphotyrosine residues of
EGFR (pY845, pY1068, pY1086, and pY1173). The
resultant ratio of phosphorylation over the total EGFR
signals was calculated, and the normalized ratio was
used to calculate fold changes over medium control.
Data are representative of three independent
experiments.
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Figure 6 Schematic for SILAC-based quantitative analysis. The exper-
imental scheme for SILAC-based quantitative phosphoproteome analysis
includes culturing HCLEs with SILAC-labeled with heavy- or light-labeled
lysine and arginine. The heavy [13C6,
15N2 (K),
13C6,
15N4 (R)] and light
[12C6,
14N2(K),
12C6,
14N4(R)] isotope-labeled cells were transfected with
siRNA directed to P2Y2 receptor and NT (scrambled sequence), respectively.
Cells were stimulated with 100 mmol/L UTP for 5 minutes and then lysed,
and equal amounts of total protein from each condition were mixed. Lysate
was reduced, alkylated and trypsin digested, and subjected to immuno-
precipitation using anti-phosphotyrosine antibody. Eluted peptides were
further phosphoenriched using IMAC and analyzed using a nanoAcuity UPLC
(Waters Corp) coupled through a TriVersa NanoMate (Advion) to an LTQ-
Orbitrap mass spectrometer (ThermoFisher Scientiﬁc).
Table 2 Relative Role of P2Y2 Receptor on Tyrosine Phosphorylation
Sequence Modiﬁcations Ratio H/L
EGFR p-Tyr-974 0.345
p-Tyr-1086 0.230
p-Tyr-1148 0.779
p-Tyr-1173 1.215
Src p-Tyr-421 0.339
p-Tyr-446 0.128
SHC p-Tyr-42 0.694
MAPK-1 p-Tyr-187 0.789
Paxillin p-Tyr-118 0.100
Subset of SILAC-based quantitative phosphorylation proﬁle from cells
transfected with siRNA to P2Y2 receptor and stimulated with UTP (H)
compared with cells transfected with siRNA to nontargeting sequence (L)
(see Figure 6). Phosphorylation is presented as the ratio of H/L.
Kehasse et alEqual amounts of total protein from each condition were
mixed and digested using trypsin. Desalted peptides were
immunoprecipitated, and the double-label data reﬂected
changes in phosphorylation because of the P2Y2 receptor
(Figure 6 and Table 2). For example, in Figure 3, we
detected a distinct increase in phosphorylation of three
EGFR tyrosine residues (Y974, Y1086, and Y1148)
in response to nucleotides, albeit lower than in response
to EGF. After P2Y2 receptor knockdown, there was a
>50-fold decrease in phosphorylation of EGFR tyrosine
residues Y974 and Y1086, with a lesser decrease in phos-
phorylation of Y1148 after UTP stimulation (Table 2). In
addition, there was no change in phosphorylation of Y1173
(Figure 6 and Table 2). Furthermore, there was a decrease in
phosphorylation on Src, Shc, MAPK-1, and paxillin. Dif-
ferences in the phosphorylation states of the residues indicate
the high degree of complexity caused by the simultaneous
transactivation and direct activation by ligands that occurs
with injury.
Discussion
Re-epithelialization is important to the healing process, and
proper closure of wounds requires neighboring cells to
signal and communicate. The release of nucleotides on
injury activates the purinergic receptors of the cornea,
resulting in Ca2þ mobilization and cell-cell communication.
This article demonstrates the novel contribution from acti-
vation of purinergic receptors on phosphorylation of speciﬁc
residues of EGFR and downstream signaling proteins.
Moreover, the results of this work highlight the critical role
of the P2Y2 receptor in mediating epithelial migration.
Knowledge of the speciﬁc changes in phosphorylation that
occur with injury is essential to understanding how cell
migration and wound repair can be compromised.
More than 300 phosphorylation sites on 139 proteins
were identiﬁed and quantiﬁed. We demonstrated that the use1850of a combination of phosphopeptide fractionation and
phosphoenrichment strategies is important to achieve a
comprehensive analysis of complex biological samples. We
speculate that the qualitative and quantitative differences in
the levels of phosphorylation at each individual site may
cause distinct effects on their respective downstream
signaling pathways and the biological response(s) that they
mediate. As shown, EGFR tyrosine residues exhibit
spatiotemporal dynamics in phosphorylation,26,29 and the
modiﬁcations are dose dependent.30 An important factor is
the concentration of agonist. Phosphorylation is often
examined under conditions in which the levels of agonist are
much higher than would be encountered in vivo. Although
these types of studies facilitate the analysis, they can mask
important changes. Therefore, we used concentrations of
EGF at least ﬁvefold lower than those used in most of the
previously reported mass spectrometryebased phospho-
proteome studies.22,29e31 Although the threshold at which
the phosphorylation level of proteins results in a biological
response is not yet known, increasing evidence implicates a
direct relationship between the degree of phosphorylation
and the corresponding signaling strength. These changes in
phosphorylation may occur in response to distinct ligands or
under unique cellular environments. In addition, there are
other modiﬁcations that we have not yet addressed,
including changes in O-GlcNAcylation that will be exam-
ined in future studies. Changes in glycosylation may cause
cryptic sites and modify signaling.
Although the release of nucleotides and activation of
purinergic receptors have been known to cause trans-
activation of EGFR and recruitment of downstream sig-
naling proteins that is distinct from EGF, the previous
reliance on phosphorylated antibodies targeted to generic
modiﬁcations had not permitted determination of site-
speciﬁc modiﬁcations.14 Herein, we demonstrate that di-
rect activation of EGFR with EGF and transactivation of
EGFR via activation of purinergic receptors result in distinct
phosphorylation proﬁles of EGFR residues. We have shown
that the activation of purinergic receptor subtypes is ligand
speciﬁc; the patterns of polar amino acid residues in theajp.amjpathol.org - The American Journal of Pathology
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the P2Y receptors allow one to account for ligand speci-
ﬁcity.32 Gan et al24 used a glioblastoma tumor cell line to
demonstrate that mutation of one or more EGFR tyrosine
residues affected the degree of phosphorylation of sites.
They showed that mutation of EGFR tyrosine residue
Y1173F led to increased phosphorylation of other sites.
Although the EGFR tyrosine residue Y1173 is probably the
most reported site of phosphorylation on EGFR, in HCLEs,
this site has a basal level of phosphorylation, and although
direct activation of EGFR results in its phosphorylation, the
process does not appear to be mediated by activation of the
P2Y2 receptor. This was veriﬁed in our SILAC experiments,
in which knockdown of the P2Y2 receptor and stimulation
with UTP resulted in decreased phosphorylation of Y974,
Y1086, and Y1148 but no change in Y1173 phosphoryla-
tion compared with control. Thus, this method of experi-
mentation and analysis allowed us to compare protein
expression and modiﬁcation in cells and, despite the low
stoichiometry of tyrosine phosphorylation and the use of
low levels of agonist, the analytical sensitivity yielded
highly conﬁdent results.
We further determined that the agonist-speciﬁc induced
phosphorylation of EGFR selectively modiﬁed down-
stream signaling proteins (eg, PLC-g1, Shc, PKC, Src,
paxillin, FAK, and MAPK). For instance, among the PKC
isoforms, only PKCD was more highly phosphorylated by
ATP than EGF on Y313 and S304. In addition, we found
that paxillin was more highly phosphorylated by ATP at
four tyrosine and serine residues compared with EGF,
whereas FAK has one site more highly phosphorylated by
ATP and another by EGF. These data, along with the in-
crease in the P2Y2 receptor mRNA with migration, indi-
cated the importance of this receptor in wound repair.
After culture of cells in stable isotope-labeled amino acids
and knockdown of the P2Y2 receptor, we detected that the
phosphorylation of speciﬁc residues on proteins described
previously (eg, Y446 on Src, Y118 on paxillin, and Y1068
on EGFR) was reduced by >50%, indicating that their
signaling correlated with the activation of this receptor.
Previous studies have shown that mutation of Y1068 on
EGFR reduces directional migration.14 Furthermore, this
site is reduced under hypoxic conditions in which mi-
gration is attenuated in vitro and in organ culture models
(data not shown). These indicate that the P2Y2 receptor
does mediate a subset of downstream signaling proteins
directly correlated to migration. The modiﬁcations of
other proteins that are phosphorylated on activation by
nucleotides may be mediated by other purinergic receptors
and are a topic of future studies. The results from our
current studies indicate residues that will be of interest to
investigate. Moreover, the differential phosphorylation of
speciﬁc residues on EGFR and downstream molecules
indicates that it is imperative to examine speciﬁc sites on
these and other dynamically modiﬁed phosphoproteins in
pathological tissue, where wound repair is compromised.The American Journal of Pathology - ajp.amjpathol.orgAcknowledgments
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